KMO, or Kynurenine 3-monooxygenase, is an enzyme that plays a key role in the kynurenine pathway, which is involved in the metabolism of the amino acid tryptophan. This enzyme is important because it influences the balance between different metabolites in the kynurenine pathway, which can have various effects on the body. KMO activity, therefore, has significant implications for brain health and is a focus of research in conditions such as Alzheimer's disease, Huntington's disease, and schizophrenia....
Testing KMO activity can be particularly beneficial for:
Dysregulated KMO activity can lead to an imbalance in the kynurenine pathway, potentially resulting in various symptoms, particularly related to neurological and mental health:
Several factors can impact the activity of KMO:
Regulating KMO activity typically involves addressing the broader factors that influence the kynurenine pathway: